CD34

88184, 88185, 88187, 86367

CD3/19

88184, 88185, 88187, 86355, 86359

CD4/8

88184, 88185, 88187, 86360

CFU

88237

L01012

HLA Antibody Screen

86807, 86922, 86021

L01042

Lymphocyte Crossmatch

86805, 86922

L01010

HLA I (A,B) IR For Platelet Transfusions

83891, 83900, 83901x50, 83894x50, 83912x50

L01095

HLA (A,B,DR) IR

83891, 83900, 83901x99, 83894x99, 83912x99

L01011

HLA I DNA (A,B,C) IR

83891, 83900, 83901x99, 83894x99, 83912x99

L01013

HLA I DNA (A,B,C) HR

83891, 83900, 83901x206, 83894x206, 83912x206

L01020

HLA II (DR,DQ) IR

83891, 83900, 83901x121, 83894x121, 83912x121

L01021

HLA II (DR,DQ) HR

83891, 83900, 83901x195, 83894x195, 83912x195

L01017

HLA-A Supplemental HR

83891, 83900, 83901x64, 83894x64, 83912x64

L01022

HLA-B Supplemental HR

83891, 83900, 83901x74, 83894x74, 83912x74

L01023

HLA-C Supplemental HR

83891, 83900, 83901x51, 83894x51, 83912x51

L01051

HLA Single Locus IR (e.g., B27 or DQ2 & DQ8)

83891, 83900, 83901x14, 83894x14, 83912x14

L01026

HLA-DRB1 Supplemental HR

83891, 83900, 83901x74, 83894x74, 83912x74

L01025

HLA-DRB3/4/5 Supplemental HR

83891, 83900, 83901x53, 83894x53, 83912x53

L01024

HLA-DQB1 Supplemental HR

83891, 83900, 83901x55, 83894x55, 83912x55

L01032

HLA-DPA1 HR

83891, 83900, 83901x66, 83894x66, 83912x66

L01040

HLA-DPB1 HR

83891, 83900, 83901x74, 83894x74, 83912x74

L01041

HLA-DQA1 HR

83891, 83900, 83901x74, 83894x74, 83912x74

L01092

HLA (A,B,C) Supplemental HR

83891, 83900, 83901x199, 83894x199, 83912x199

L01093

HLA (DR,DQ) Supplemental HR

83891, 83900, 83901x192, 83894x192, 83912x192

L01094

HLA (A,B,C) IR (DR,DQ) HR

83891, 83900, 83901x299, 83894x299, 83912x299

L01096

HLA (A,B,C,DR,DQ) HR for Cord Blood Typing

83891x2, 83900, 83901x407, 83894x407, 83912x407

L03061.EX

Whole Genome Amplification Charge  (if needed)

NA

L02298

STAT Charge (7:30am-4:00pm MST weekdays)

NA

L02299

STAT Charge (after 4:00pm weekdays, weekends, holidays)

NA

83891

Isolation or extraction of highly purified nucleic acid

83900

Amplification of patient nucleic acid, multiplex, first two nucleic sequences

83901

Amplification of patient nucleic acid, multiplex, each additional acid sequence
(used with 83900)

83894

Separation by gel electrophoresis (eg, agarose, polyacrylamide)

83912

Interpretation and report

86805

Lymphocytotoxicity assay, visual crossmatch; with titration

86807

Serum screening for cytotoxic percent reactive antibody (PRA); standard method

86922

Antiglobulin technique

86021

Antibody identification; leukocyte antibodies

88184

Flow cytometry, cell surface, cytoplasmic or nuclear marker, technical component only;
first marker

88185

Flow cytometry, cell surface, cytoplasmic or nuclear marker, technical component only;
each additional marker

88187

Flow cytometry, interpretation; 2 to 8 markers

86367

Stem cells (ie, CD34), total count

86355

B cells; total count

86359

T cells; total count

86360

Absolute CD4 and CD8 count, including ratio

88237

Bone marrow, blood cells